Optimizing intralesional triamcinolone acetonide treatment for isolated nail psoriasis: a pilot, intra-subject randomized controlled trial

被引：3
|
作者：
Ricardo, Jose W. [1 ]
Qiu, Yuqing [2 ]
Lipner, Shari R. [1 ]
机构：
[1] Weill Cornell Med, Dept Dermatol, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA
来源：
ARCHIVES OF DERMATOLOGICAL RESEARCH | 2024年 / 316卷 / 04期
关键词：
Nails; Psoriasis; Triamcinolone acetonide; Intralesional;
D O I：
10.1007/s00403-024-02849-w
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：4
相关论文
共 47 条
  • [41] Optimizing the frequency of outpatient short-contact dithranol treatment used in combination with broadband ultraviolet B for psoriasis: a randomized, within-patient controlled trial
    McBride, SR
    Walker, P
    Reynolds, NJ
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (06) : 1259 - 1265
  • [42] Erratum to: Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial
    Celine Busard
    Stef Menting
    SJ van Bezooijen
    Juul van den Reek
    Barbara Hutten
    Errol Prens
    Elke de Jong
    Martijn van Doorn
    Phyllis Spuls
    Trials, 18
  • [43] CONCORDANCE OF BASELINE PAIN MEASURES (ACROSS TWO REPORTING INSTRUMENTS) INFLUENCES TREATMENT EFFECT: POST HOC ANALYSIS OF A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE IN PATIENTS WITH KNEE OSTEOARTHRITIS
    Conaghan, P. G.
    Ross, E.
    Kivitz, A.
    Turk, D. C.
    Spitzer, A. I.
    Jones, D. G.
    Lanier, R.
    Cinar, A.
    Lufkin, J.
    Kelley, S. D.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S492 - S493
  • [44] Concordance of Baseline Pain Measures (Across Two Reporting Instruments) Influences Treatment Effect: Post Hoc Analysis of a Phase 3 Randomized Controlled Trial of Triamcinolone Acetonide Extended-Release in Patients with Knee Osteoarthritis
    Conaghan, Philip G.
    Ross, Edgar
    Kivitz, Alan
    Turk, Dennis
    Spitzer, Andrew
    Jones, Deryk
    Lanier, Ryan
    Cinar, Amy
    Lufkin, Joelle
    Kelley, Scott
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [45] Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)
    Busard, Celine
    Menting, Stef
    van Bezooijen, S. J.
    van den Reek, Juul
    Hutten, Barbara
    Prens, Errol
    de Jong, Elke
    van Doorn, Martijn
    Spuls, Phyllis
    TRIALS, 2017, 18
  • [46] Optimizing pain treatment interventions (OPTI): A pilot randomized controlled trial of collaborative care to improve chronic pain management and opioid safety-Rationale, methods, and lessons learned
    Seal, Karen H.
    Borsari, Brian
    Tighe, Jennifer
    Cohen, Beth E.
    Delucchi, Kevin
    Morasco, Benjamin J.
    Li, Yongmei
    Sachs, Emily
    Abadjian, Linda
    Watson, Erin C.
    Manuel, Jennifer K.
    Vella, Lea
    Trafton, Jodie
    Midboe, Amanda
    CONTEMPORARY CLINICAL TRIALS, 2019, 77 : 76 - 85
  • [47] EFFECTS OF ADALIMUMAB ADDED TO TREAT-TO-TARGET STRATEGY WITH METHOTREXATE AND INTRA-ARTICULAR TRIAMCINOLONE ON LIPIDS IN EARLY- AND TREATMENT NAIVE RHEUMATOID PATIENTS: SECONDARY ANALYSES FROM THE MULTICENTER DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED OPERA TRIAL
    Masic, D.
    Stengaard-Pedersen, K.
    Logstrup, B. B.
    Horslev-Petersen, K.
    Hetland, M. L.
    Junker, P.
    Ostergaard, M.
    Ammitzbol, C.
    Moller, S.
    Christensen, R.
    Ellingsen, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 607 - 607
12345